- Home
- MOGU vs CTXR Comparison
MOGU vs CTXR Comparison
Compare MOGU & CTXR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MOGU
- CTXR
- Stock Information
- Founded
- MOGU 2011
- CTXR 2007
- Country
- MOGU China
- CTXR United States
- Employees
- MOGU N/A
- CTXR N/A
- Industry
- MOGU Business Services
- CTXR Biotechnology: Pharmaceutical Preparations
- Sector
- MOGU Consumer Discretionary
- CTXR Health Care
- Exchange
- MOGU Nasdaq
- CTXR Nasdaq
- Market Cap
- MOGU 19.8M
- CTXR 22.1M
- IPO Year
- MOGU 2018
- CTXR N/A
- Fundamental
- Price
- MOGU $2.66
- CTXR $1.29
- Analyst Decision
- MOGU
- CTXR Strong Buy
- Analyst Count
- MOGU 0
- CTXR 3
- Target Price
- MOGU N/A
- CTXR $53.00
- AVG Volume (30 Days)
- MOGU 13.2K
- CTXR 1.5M
- Earning Date
- MOGU 11-21-2025
- CTXR 08-12-2025
- Dividend Yield
- MOGU N/A
- CTXR N/A
- EPS Growth
- MOGU N/A
- CTXR N/A
- EPS
- MOGU N/A
- CTXR N/A
- Revenue
- MOGU $19,462,964.00
- CTXR N/A
- Revenue This Year
- MOGU N/A
- CTXR N/A
- Revenue Next Year
- MOGU N/A
- CTXR $731.60
- P/E Ratio
- MOGU N/A
- CTXR N/A
- Revenue Growth
- MOGU N/A
- CTXR N/A
- 52 Week Low
- MOGU $1.83
- CTXR $0.65
- 52 Week High
- MOGU $8.10
- CTXR $12.84
- Technical
- Relative Strength Index (RSI)
- MOGU 36.97
- CTXR 42.75
- Support Level
- MOGU $2.55
- CTXR $1.50
- Resistance Level
- MOGU $2.94
- CTXR $1.60
- Average True Range (ATR)
- MOGU 0.13
- CTXR 0.19
- MACD
- MOGU -0.04
- CTXR -0.04
- Stochastic Oscillator
- MOGU 21.64
- CTXR 2.21
About MOGU MOGU Inc.
MOGU Inc is an online service provider in China, operating a KOL-driven online fashion and lifestyle platform, Mogujie, and providing customized online branding solutions to businesses. The company, on its platform, provides content related to fashion and lifestyle guides in various multimedia formats, which include Live Video Broadcasts, Short-form Videos, Photography, and an Online Review Community. The company derives revenues from within China. It also provides online marketing, commission, financing, technology, and other relevant services to merchants and users, as well as technology services to brand owners.
About CTXR Citius Pharmaceuticals Inc.
Citius Pharmaceuticals Inc is a biopharmaceutical company with a focus on anti-infectives in adjunct cancer care, prescription products, and stem cell therapy. The company is currently advancing four proprietary product candidates namely, LYMPHIR for the treatment of patients with persistent or recurrent cutaneous T-cell lymphoma. Mino-Lok, which is an antibiotic lock solution used to treat patients with catheter-related bloodstream infections, Mino-Wrap, a liquifying gel-based wrap for reduction of tissue expander infections following breast reconstructive surgeries, Halo-Lido, a topical formulation that is intended to provide anti-inflammatory and anesthetic relief to persons suffering from hemorrhoids, and others.